RFI PrecisionFDA.docx
DOCX document 21 KB Posted
- Attached to
- PrecisionFDA Request for Information
- Solicitation number
- 75F40125Q00036
About this file
This document is a Request for Information (RFI) from the Food and Drug Administration (FDA) regarding their PrecisionFDA program. PrecisionFDA is a secure cloud-based portal, analysis platform, and data repository that enables collaboration and sharing of large datasets by reviewers, bioinformaticians, researchers, and data scientists from industry, academia, government, and other partners.
The purpose of this RFI is to gather information from interested businesses on their technical capabilities to provide the full range of services described in the attached Statement of Work (SOW). The FDA will use this market research information to assess the market's capability to successfully meet the PrecisionFDA requirements. Responses should provide details on the proposed solutions to meet the SOW requirements and should not contain any sensitive business information. Responses are due by 12:00 PM EST on November 14, 2024 and should be submitted via email. The FDA does not intend to make a selection decision or award a contract based on the responses received.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
PrecisionFDA Request for Information
Background:
This Sources Sought Request for Information (RFI) is for information, planning and market research purposes only and shall not be construed as either a solicitation or obligation on the part of the Food and Drug Administration or its Centers. The purpose of this RFI is to help the FDA understand the technical capabilities for providing the full range of services described in the Statement of Work (SOW) attached at the end. FDA will use this market research information to assess the market's capability to successfully meet the PrecisionFDA requirements.
FDA welcomes responses from all interested businesses. FDA does not intend to make a selection decision or award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted or FDA's use of such information.
Acknowledgment of receipt of responses will not be made, no questions will be answered, nor will respondents be notified of the outcome of the FDA's review of the information received. Additionally, the FDA does not intend to hold discussions concerning this RFI with any interested parties. However, FDA reserves the right to contact vendors if additional information is required.
General Instructions:
A complete response to the RFI should include answers to all of the questions below. Please note that a respondent's failure to provide a complete response to a question will be interpreted to mean that it does not understand the question and does not demonstrate the capability to provide services required. Responses should demonstrate capability, not merely affirm the respondent's capability (e.g.: The response must go beyond the statement that, "XYZ company can provide training support.").
Responses to the RFI related to company capabilities (questions 1-2) should not exceed 5 pages in length. Comments and questions regarding the SOWs (questions 2) are not subject to a page limitation. The RFI responses should be submitted via email to Jada Scott at jada.scott@fda.hhs.gov by 12:00 PM EST on November 14, 2024. E-Mail is the only acceptable method of delivery for this sources sought notice.
Questions:
1. The SOW describes the background, objective, requirements, deliverables, place of performance, period of performance, and inspection and acceptance criteria for PrecisionFDA. Please briefly describe your proposed solutions to meet the requirements specified on the SOW.
2. Responses shall not contain any information that requires a non-disclosure agreement or has sensitive business information.
Attachments:
Statement of Work
File details come from the government source that posted it. Updated .